| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |